- Country: Czech Republic
- Summary: Lecive Ponutinib, Ibrutinibu, Idelalisibu
- CZT Ref No: 64068999
- Deadline: 04 Apr 2022
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: Z2022-008838
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Lecive Prepare Ponatinib, Ibrutinib, Idelalisibu Home
DESCRIPTION OF THE CONTRACTION: Inclusion of Ramcova's purchasing contracts for the surgery of lecologists, in storage and preceding the amount of documentation for 24 months on the ramcove contracts with one supplier.
VAT VALUE: 56 750 000.00
Currency: CZK
Date of publication in VVZ: 07.03.2022 20830
Type: suppliers
Place of delivery: Hematology and Blood Transfusion, at Hospital 2094/1, 12800 Praha 2 - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINLecive Ponutinib, Ibrutinibu, Idelalisibu - Czech Tender
The CLIMB HEMATOLOGY AND BLOOD TRANSFUSION, a Government sector organization in Czech Republic, has announced a new tender for Lecive Ponutinib, Ibrutinibu, Idelalisibu. This tender is published on CzechTenders under CZT Ref No: 64068999 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2022-04-04.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
